Epigenomics AG EPGNF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.65
- Day Range
- $0.50–0.50
- 52-Week Range
- $0.50–4.65
- Bid/Ask
- $0.01 / $228,802.45
- Market Cap
- $426,708.50
- Volume/Avg
- 357 / 348
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 4.47
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 0.35%
Company Profile
Epigenomics AG is a molecular diagnostics company, that focuses on developing and commercializing in vitro diagnostic liquid biopsy tests for the screening, early detection, and diagnosis of cancer. The company develops and markets procedures and devices for the production in quantity of particular epigenetic parameters such as DNA methylation patterns as well as the information technology bases necessary for their procurement and evaluation. It is engaged in the development of novel molecular diagnostic products for cancer. The company products include Epi proColon, Epi BiSKit, HCCBloodTest, and Epi proLung. The company operates in Europe, Asia, and North America, majority of its revenue derives from Asia.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- 18
- Website
- https://www.epigenomics.com
Valuation
|
Metric
|
EPGNF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.03 |
Price/Sales | 4.47 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
EPGNF
|
|---|---|
Quick Ratio | 1.81 |
Current Ratio | 1.93 |
Interest Coverage | −162.76 |
Quick Ratio
EPGNF
Profitability
|
Metric
|
EPGNF
|
|---|---|
Return on Assets (Normalized) | −100.55% |
Return on Equity (Normalized) | −150.61% |
Return on Invested Capital (Normalized) | −140.63% |
Return on Assets
EPGNF
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Fwzznxmmv | Kyxgg | $209.3 Bil | |
DHR
| Danaher Corp | Dycqdjwbmr | Lcfkbnx | $182.1 Bil | |
IQV
| IQVIA Holdings Inc | Ymhfzwt | Mrcvk | $43.4 Bil | |
IDXX
| IDEXX Laboratories Inc | Mlsfksbzf | Ndrdpk | $41.0 Bil | |
A
| Agilent Technologies Inc | Ylxgtqwms | Xxwk | $40.3 Bil | |
MTD
| Mettler-Toledo International Inc | Mssjbsqzc | Sshmn | $26.4 Bil | |
ICLR
| Icon PLC | Hcjwdkkj | Tskjzs | $24.8 Bil | |
ILMN
| Illumina Inc | Qktgwghx | Zwddpnk | $19.3 Bil | |
WAT
| Waters Corp | Dqrlzmhgp | Lsnd | $18.3 Bil | |
LH
| Laboratory Corp of America Holdings | Mxwqjfnyxv | Rhrzsd | $17.5 Bil |